Aethlon Medical (AEMD) FCF Margin (2016 - 2023)
Historic FCF Margin for Aethlon Medical (AEMD) over the last 13 years, with Q1 2023 value amounting to 515.11%.
- Aethlon Medical's FCF Margin rose 247324900.0% to 515.11% in Q1 2023 from the same period last year, while for Dec 2023 it was 1875.22%, marking a year-over-year increase of 881042600.0%. This contributed to the annual value of 164.1% for FY2025, which is N/A changed from last year.
- Per Aethlon Medical's latest filing, its FCF Margin stood at 515.11% for Q1 2023, which was up 247324900.0% from 25247.61% recorded in Q1 2022.
- Aethlon Medical's FCF Margin's 5-year high stood at 310.67% during Q4 2019, with a 5-year trough of 25247.61% in Q1 2022.
- In the last 5 years, Aethlon Medical's FCF Margin had a median value of 1599.05% in 2021 and averaged 5359.1%.
- Its FCF Margin has fluctuated over the past 5 years, first tumbled by -186928700bps in 2022, then soared by 247324900bps in 2023.
- Quarter analysis of 5 years shows Aethlon Medical's FCF Margin stood at 310.67% in 2019, then dropped by -15bps to 356.7% in 2020, then plummeted by -4447bps to 16218.1% in 2021, then tumbled by -56bps to 25247.61% in 2022, then surged by 98bps to 515.11% in 2023.
- Its FCF Margin was 515.11% in Q1 2023, compared to 25247.61% in Q1 2022 and 16218.1% in Q4 2021.